Cardiology

The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.

ADA 2019--Linagliptin, the DPP-4 inhibitor, showed similar risk for first or recurrent CV events or hopspitalization vs placebo in T2DM patients with high cardiorenal risk in CARMELINA subanalysis.

ADA 2019-Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.

Patients know that regular exercise is important but often need guidance on what's best. A pulmonologist advises on how to asses individual needs, utilize guidelines, and create a plan.

A personal EKG monitor, an app that wirelessly connects to a smart thermometer, and 3 more FDA-cleared apps for primary care. 

Test your knowledge of the key elements and outcomes of the highly buzzed about REDUCE-IT trial with this 5-question quiz.

Eighty percent of all cardiovascular events are preventable. The ACC/AHA 2019 guidelines are a single source of best practices to help achieve that goal. Review them here, at-a-glance.

From a mobile EKG monitor to a digital urinalysis app, these medical "devices" are changing the way healthcare is delivered.

Dapagliflozin, icosapent ethyl, and bempedoic acid were found to reduce clinical or surrogate CV endpoints in studies presented at ACC.19, March 16-18, in New Orleans, LA.

Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.

Psoriasis medication for heart disease prevention, the role of artificial sweeteners in different types of stroke, and 3 other noteworthy findings from American Heart Month. 

What approach is now AHA/ACC guideline-recommended for a patient with primary hypercholesterolemia, with an LDL-C of 192 mg/dL? Take Quiz #3.

From a mobile fluid tracker to an app with a 3-D beating heart, these are the top 5 heart failure apps that every primary care physician and patient should know about. 

How will changes in the AHA/ACC update to the 2013 guidelines help optimize care for patients with ASCVD? Try part 2 of our 3-part quiz and find out.

What's new and what's not in the AHA/ACC 2018 update to the 2013 lipid management guidelines? Try part I of our 3-part quiz and find out.

Other than sleep problems, this 52-year-old has no other medical history. What's your ECG read? Does the computer assessment agree?

As the new year begins, several developments in heart health research are making the news.

The 82-year-old is observed to be in respiratory distress but denies any symptoms. See the ECG for more information. Your dx?

The 32-yr-old claims no medical history other than "thyroid surgery" and takes no medications. What does the ECG suggest?

What impact does this highly purified form of omega-3 fatty acid have on cardiovascular events? Authors of the REDUCE-IT trial sought to find out. 

Under what circumstance/s is it appropriate to initiate treatment for hypertension with a single drug (followed by titration, additional agents)?

ECG Challenge: A 32-year-old woman is brought by ambulance to the ED. She is having palpitations after consuming 2 energy drinks. What's your ECG read?

Three abstracts from AHA 2018 shed light on long-term impacts of smoking (and cessation) on CV disease and how CV disease influences sedentary behavior. 

The optimal choice of medication to bind excess phosphate in patients with advanced CKD won't always be straightforward.

To Rx or not to Rx aspirin - is one of our 8 questions based on new research that highlights costs vs benefits of aspirin therapy.